Overview: Oral Convenience vs Injectable Precision
MK-677 (Ibutamoren) and Ipamorelin both stimulate growth hormone release through the ghrelin receptor, but their delivery methods and pharmacokinetics are fundamentally different. MK-677 is an orally active, non-peptide GH secretagogue with a 24-hour duration of action — producing sustained GH and IGF-1 elevation. Ipamorelin is an injectable peptide with a short half-life that produces discrete, natural-pattern GH pulses. This difference in GH release pattern (sustained vs pulsatile) has significant implications for research outcomes in test subjects. For research purposes only.
Head-to-Head Comparison Table
Administration: MK-677 = Oral (capsule/liquid) | Ipamorelin = Subcutaneous injection
Half-life: MK-677 = 24 hours | Ipamorelin = ~2 hours
GH release pattern: MK-677 = Sustained 24hr elevation | Ipamorelin = Discrete pulses
IGF-1 elevation: MK-677 = Significant and sustained | Ipamorelin = Moderate and transient
Dose: MK-677 = 10-25 mg daily (oral) | Ipamorelin = 100-250 mcg 1-3x daily (injection)
Hunger increase: MK-677 = Significant | Ipamorelin = None
Water retention: MK-677 = Common | Ipamorelin = Rare
Blood glucose impact: MK-677 = May increase | Ipamorelin = Minimal
Sleep improvement: MK-677 = Strong | Ipamorelin = Moderate
Cycle length: MK-677 = 8-12 weeks | Ipamorelin = 12-16 weeks
Convenience: MK-677 = High (no injections) | Ipamorelin = Lower (daily injections)
Selectivity: MK-677 = Low | Ipamorelin = Very high
Which to Choose for Research
Choose MK-677 when: Oral administration is required for the protocol, sustained 24-hour GH/IGF-1 elevation is the research objective, injection compliance is a concern, or the study investigates long-acting ghrelin receptor agonism in test subjects.
Choose Ipamorelin when: Natural pulsatile GH release is preferred, selective GH stimulation without hunger/water retention is required, the protocol involves stacking with CJC-1295, or clean pharmacological data without confounding side effects is needed in test subjects.
Ipamorelin produces more physiological GH release patterns, while MK-677 offers convenience and sustained elevation. Many researchers consider Ipamorelin superior for quality of GH stimulation despite the injection requirement. For research purposes only.
